Advanced Vascular Dynamics (AVD) announced U.S. Food and Drug Administration (FDA) clearance and CE mark for the RadAR vascular compression devices for post-procedure hemostasis of tibiopedal access sites, including the dorsalis pedis and posterior tibial arteries. The RadAR devices were previously cleared for use for post-catheterization radial artery hemostasis.

AliveCor Inc. announced the launch of its third-generation AliveCor Heart Monitor. Now users have the ability to identify and manage heart conditions with a U.S. Food and Drug Administration (FDA)-cleared electrocardiogram (ECG) monitor, anywhere and at anytime. The third-generation device is now 50-percent thinner and 40-percent lighter and was designed from first-hand customer feedback and in collaboration with global design firm IDEO.


According to the Dell Global Technology Adoption Index, 96 percent of mid-size healthcare organizations surveyed are using or considering using cloud computing.

Veniti Inc. announced that it has enrolled the first United States patients in the Virtus trial of the Veniti VICI Venous Stent System.

With the introduction of the Aplio 300 and 500 Platinum Series from Toshiba America Medical Systems Inc., clinicians can now meet goals of the Centers for Medicare & Medicaid Services’ (CMS) Triple Aim. 

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now